127 related articles for article (PubMed ID: 2658574)
1. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group.
Am J Med; 1989 Jun; 86(6 Pt 1):668-72. PubMed ID: 2658574
[TBL] [Abstract][Full Text] [Related]
2. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.
Pizzo PA; Robichaud KJ; Gill FA; Witebsky FG
Am J Med; 1982 Jan; 72(1):101-11. PubMed ID: 7058815
[No Abstract] [Full Text] [Related]
3. Pre-emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer.
Uneno Y; Imura H; Makuuchi Y; Tochitani K; Watanabe N
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013604. PubMed ID: 36440894
[TBL] [Abstract][Full Text] [Related]
4. Development of a Method of Measuring β-D-Glucan and Its Use in Preemptive Therapy for Invasive Fungal Infections.
Yoshida M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502174
[TBL] [Abstract][Full Text] [Related]
5. Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Spain (GETH-MIC).
López-Sánchez C; Valcárcel D; Gómez V; López-Jiménez J; Serrano D; Rubio V; Solano C; Vázquez L; Ruiz I;
Rev Esp Quimioter; 2020 Apr; 33(2):110-115. PubMed ID: 32056418
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Invasive Aspergillosis in High-Risk Patients: Universal Versus Preemptive, Targeted Treatment.
Baddley JW; Apewokin S
Curr Fungal Infect Rep; 2008 Jun; 2():61-68. PubMed ID: 28959373
[TBL] [Abstract][Full Text] [Related]
7. Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis.
Chen K; Wang Q; Pleasants RA; Ge L; Liu W; Peng K; Zhai S
BMC Infect Dis; 2017 Feb; 17(1):159. PubMed ID: 28219330
[TBL] [Abstract][Full Text] [Related]
8. Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China.
Yuan W; Ren J; Guo X; Guo X; Cai S
Med Sci Monit; 2016 Nov; 22():4226-4232. PubMed ID: 27819257
[TBL] [Abstract][Full Text] [Related]
9. Antifungal Therapy in Hematopoietic Stem Cell Transplant Recipients.
Busca A; Pagano L
Mediterr J Hematol Infect Dis; 2016; 8(1):e2016039. PubMed ID: 27648202
[TBL] [Abstract][Full Text] [Related]
10. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
Patterson TF; Thompson GR; Denning DW; Fishman JA; Hadley S; Herbrecht R; Kontoyiannis DP; Marr KA; Morrison VA; Nguyen MH; Segal BH; Steinbach WJ; Stevens DA; Walsh TJ; Wingard JR; Young JA; Bennett JE
Clin Infect Dis; 2016 Aug; 63(4):e1-e60. PubMed ID: 27365388
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic-driven antifungal therapy in neutropenic patients using the D-index and serial serum galactomannan testing.
Garnica M; Sinhorelo A; Madeira L; Portugal R; Nucci M
Braz J Infect Dis; 2016; 20(4):354-9. PubMed ID: 27280789
[TBL] [Abstract][Full Text] [Related]
12. Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).
Boğa C; Bolaman Z; Çağırgan S; Karadoğan İ; Özcan MA; Özkalemkaş F; Saba R; Sönmez M; Şenol E; Akan H; Akova M
Turk J Haematol; 2015 Jun; 32(2):100-17. PubMed ID: 26316478
[TBL] [Abstract][Full Text] [Related]
13. Opportunistic infection in patients with acute liver failure.
Arai M; Kanda T; Yasui S; Fujiwara K; Imazeki F; Watanabe A; Sato T; Oda S; Yokosuka O
Hepatol Int; 2014 Apr; 8(2):233-9. PubMed ID: 26202504
[TBL] [Abstract][Full Text] [Related]
14. Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update.
Villafuerte-Gutierrez P; Villalon L; Losa JE; Henriquez-Camacho C
Adv Hematol; 2014; 2014():986938. PubMed ID: 25525436
[TBL] [Abstract][Full Text] [Related]
15. Risk factor for death in hematopoietic stem cell transplantation: are biomarkers useful to foresee the prognosis in this population of patients?
Massaro KS; Macedo R; de Castro BS; Dulley F; Oliveira MS; Yasuda MA; Levin AS; Costa SF
Infection; 2014 Dec; 42(6):1023-32. PubMed ID: 25263811
[TBL] [Abstract][Full Text] [Related]
16. Routine versus selective antifungal administration for control of fungal infections in patients with cancer.
Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD000026. PubMed ID: 25188768
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1).
Akan H; Ongören Aydın S; Saltoğlu N; Cağatay A; Akalın H; Arat M; Ali R; Kalayoğlu-Beşışık S; Demir AM
Turk J Haematol; 2014 Jun; 31(2):111-20. PubMed ID: 25035667
[TBL] [Abstract][Full Text] [Related]
18. Concise review: next-generation cell therapies to prevent infections in neutropenic patients.
Brunck ME; Nielsen LK
Stem Cells Transl Med; 2014 Apr; 3(4):541-8. PubMed ID: 24598780
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and prognostic factors of empirical antifungal therapy with itraconazole in the patients with hematological malignancies: a prospective multicenter observational study in Korea.
Kim JS; Cheong JW; Shin HJ; Lee JW; Lee JH; Yang DH; Lee WS; Kim H; Park JS; Kim SH; Kim YS; Kwak JY; Chae YS; Park J; Do YR; Min YH
Yonsei Med J; 2014 Jan; 55(1):9-18. PubMed ID: 24339281
[TBL] [Abstract][Full Text] [Related]
20. Association of hospital construction with the development of healthcare associated environmental mold infections (HAEMI) in pediatric patients with leukemia.
Pokala HR; Leonard D; Cox J; Metcalf P; McClay J; Siegel J; Winick N
Pediatr Blood Cancer; 2014 Feb; 61(2):276-80. PubMed ID: 23970381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
